GMCL1 Controls 53BP1 Stability and Modulates Paclitaxel Sensitivity in Cancer
Authors:
- Yuki KitoYKYuki Kito
- Tania J González-RoblesTGTania J González-Robles
- Sharon KaisariSKSharon Kaisari
- Juhee PaeJPJuhee Pae
- Sheena Faye GarciaSGSheena Faye Garcia
- Juliana Ortiz-PachecoJOJuliana Ortiz-Pacheco
- Beatrix UeberheideBUBeatrix Ueberheide
- Ruth LehmannRLRuth Lehmann
- Antonio MarzioAMAntonio Marzio
- Gergely RonaGRGergely Rona
- Michele PaganoMPMichele Pagano
Preprint
- 23 May 2025
- preprint
- Published by eLife Sciences Publications, Ltd in eLife preprints
- Vol. 14
Abstract
The Mitotic Surveillance Pathway (MSP) monitors the duration of M-phase. Prolonged mitosis, caused by spindle attachment defects or microtubule-targeting drugs such as the taxane paclitaxel, induces the formation of the ternary “mitotic stopwatch” complex consisting of 53BP1, USP28, and p53. This event protects p53 from degradation, resulting in cell cycle arrest or apoptosis in daughter cells. In paclitaxel-resistant cancers, cells bypass the MSP, enabling unchecked proliferation and survival, although the underlying mechanisms remain unknown. Here, we demonstrate that 53BP1 physically interacts with GMCL1 but not its paralog, GMCL2, and we mapped the interaction regions on both proteins. CRL3GMCL1 functions as a ubiquitin ligase that targets 53BP1 for degradation during M phase, impacting p53 levels in daughter cells. High GMCL1 expression significantly correlates with resistance to paclitaxel in cancer cell lines with wild-type p53, including endometrial, breast, and upper aerodigestive tract cancer cells. Loss of GMCL1 restores paclitaxel sensitivity in p53 expressing cells but not in p53 deficient cells. We propose that in cancers with high GMCL1 levels, the CRL3GMCL1-mediated degradation of 53BP1 prevents the formation of the mitotic stopwatch complex, leading to p53 degradation and sustained proliferation. Finally, our results indicate that GMCL1 inhibition represents a novel strategy to restore taxane sensitivity in resistant cancers.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- CDK-independent role of D-type cyclins in regulating DNA mismatch repairMolecular Cell, 2024
- BTB domains: A structural view of evolution, multimerization, and protein–protein interactionsBioEssays, 2022
- Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activityJournal of Biological Chemistry, 2021
- Cyclin F Controls Cell-Cycle Transcriptional Outputs by Directing the Degradation of the Three Activator E2FsMolecular Cell, 2019
- GCL and CUL3 Control the Switch between Cell Lineages by Mediating Localized Degradation of an RTKDevelopmental Cell, 2017
- A New Mode of Mitotic SurveillanceTrends in Cell Biology, 2017
- Reciprocal Regulation between 53BP1 and the Anaphase-Promoting Complex/Cyclosome Is Required for Genomic Stability during Mitotic StressCell Reports, 2017
- Mitosis-targeted anti-cancer therapies: where they standCell Death & Disease, 2012
- Mutations that affect meiosis in male mice influence the dynamics of the mid-preleptotene and bouquet stagesExperimental Cell Research, 2006
- The germ cell-less gene product: A posteriorly localized component necessary for germ cell development in DrosophilaCell, 1992